Effects of Dexmedetomidine on Motor and Somatosensory Evoked Potentials during Spine Surgery
IRB Number: 14132
inactiveApril 24, 2015
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
Co-Investigators
- Michael K. Urban, MD, PhD
- Sean W. Donegan
- David Pinter
Summary
Cross over study of 34 patients, comparing the effects of two different intravenous anesthetic protocol, with and without dexmedetomidine, on motor and somatosensory evoked potentials.
Inclusion/Exclusion Criteria
Inclusion criteria are patients between ages 18 to 70 years undergoing multilevel posterior spine fusions requiring SSEP and MEP monitoring
Exclusion criteria are contraindications to any of the anesthetic medications included in the protocols, history of bradycardia and non-English speaking patients.
Contact Information
Ronald G. Emerson, MD
emersonr@hss.edu
212.774.2742